[go: up one dir, main page]

DE69727849D1 - Cyclosporin-Emulsionen - Google Patents

Cyclosporin-Emulsionen

Info

Publication number
DE69727849D1
DE69727849D1 DE69727849T DE69727849T DE69727849D1 DE 69727849 D1 DE69727849 D1 DE 69727849D1 DE 69727849 T DE69727849 T DE 69727849T DE 69727849 T DE69727849 T DE 69727849T DE 69727849 D1 DE69727849 D1 DE 69727849D1
Authority
DE
Germany
Prior art keywords
cyclosporin
oil
emulsions
cyclosporin emulsions
phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69727849T
Other languages
English (en)
Other versions
DE69727849T2 (de
Inventor
Indu Parikh
Awadhesh Mishra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RTP Pharma Corp
Original Assignee
RTP Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RTP Pharma Corp filed Critical RTP Pharma Corp
Publication of DE69727849D1 publication Critical patent/DE69727849D1/de
Application granted granted Critical
Publication of DE69727849T2 publication Critical patent/DE69727849T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69727849T 1996-04-03 1997-04-03 Cyclosporin-Emulsionen Expired - Lifetime DE69727849T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/627,187 US5660858A (en) 1996-04-03 1996-04-03 Cyclosporin emulsions
US627187 1996-04-03

Publications (2)

Publication Number Publication Date
DE69727849D1 true DE69727849D1 (de) 2004-04-08
DE69727849T2 DE69727849T2 (de) 2004-07-29

Family

ID=24513586

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727849T Expired - Lifetime DE69727849T2 (de) 1996-04-03 1997-04-03 Cyclosporin-Emulsionen

Country Status (9)

Country Link
US (1) US5660858A (de)
EP (1) EP0799620B1 (de)
JP (1) JP4212113B2 (de)
AT (1) ATE260673T1 (de)
AU (1) AU2588597A (de)
CA (1) CA2250970C (de)
DE (1) DE69727849T2 (de)
ES (1) ES2217368T3 (de)
WO (1) WO1997036611A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537012A1 (de) * 1995-10-04 1997-04-10 Dietl Hans Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
DE19810655A1 (de) * 1998-03-12 1999-09-16 Univ Eberhard Karls Arzneimittel mit einem Gehalt an Ciclosporin
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO2000010531A1 (en) 1998-08-19 2000-03-02 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
CZ20011739A3 (cs) 1998-11-20 2001-10-17 Rtp Pharma Inc. Dispergovatelné fosfolipidem stabilizované mikročástice
PT1154759E (pt) 1998-12-30 2008-11-20 Dexcel Ltd Concentrado dispersível para administração de ciclosporina
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
WO2001028519A1 (de) * 1999-10-20 2001-04-26 Vesifact Ag Mikroemulsion-prekonzentrate und mikroemulsionen
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
DE19961733A1 (de) * 1999-12-21 2001-06-28 Ciclomulsion Ag Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
EP1429749A2 (de) 2001-09-26 2004-06-23 Baxter International Inc. Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
EP1435910B9 (de) * 2001-10-19 2010-02-03 Isotechnika Inc. Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP4251988B2 (ja) * 2001-12-14 2009-04-08 ヤーゴテック アクチェンゲゼルシャフト シクロスポリンを含む医薬製剤およびその使用
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
DE10347994A1 (de) 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
EP1711163A2 (de) * 2004-02-05 2006-10-18 Baxter International Inc. Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US11311477B2 (en) * 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
NZ572003A (en) 2006-05-30 2010-07-30 Intarcia Therapeutics Inc Two-piece, internal-channel osmotic delivery system flow modulator with spiral fluid channel
WO2008021133A2 (en) 2006-08-09 2008-02-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
MX2009005726A (es) 2006-12-01 2009-09-28 Anterios Inc Nanoparticulas peptidicas y usos de las mismas.
CA2671447A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
WO2008133789A2 (en) * 2007-03-20 2008-11-06 West Virginia University C/O Office Of Technolgoy Transfer West Virginia Research Corporation Methods and compositions for targeting afap
JP5135852B2 (ja) 2007-03-30 2013-02-06 日油株式会社 可溶化用組成物
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
AR066901A1 (es) * 2007-05-18 2009-09-23 Alcon Mfg Ltd Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
EP2162117B1 (de) 2007-05-31 2018-02-21 Anterios, Inc. Nukleinsäure-nanoteilchen und ihre verwendungszwecke
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
MX340897B (es) * 2007-10-02 2016-07-29 Theranos Inc Dispositivos modulares de punto de cuidado y usos de los mismos.
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
US20110092443A1 (en) * 2009-01-08 2011-04-21 Allergan, Inc. Cyclosporine compositions for enhancing nail growth
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
CN106236708B (zh) * 2009-11-17 2020-06-26 迈克尔·A·福兰 含游离脂肪酸的抗微生物组合物
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
WO2012069149A1 (en) * 2010-11-23 2012-05-31 Merck Patent Gmbh Solution comprising cyclic oligopeptides
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
HUE045467T2 (hu) 2011-03-14 2020-01-28 Drug Delivery Solutions Ltd Szemészeti készítmény
KR101492447B1 (ko) 2013-05-20 2015-02-23 주식회사태준제약 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
IL262802B2 (en) 2016-05-16 2025-04-01 Intarcia Therapeutics Inc Glucagon receptor selective polypeptides and methods of using them
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165238A (en) * 1980-03-12 1984-04-10 Demetrios P. Papahadjopoulos Activated liposomes and method
DE68900991D1 (de) * 1988-01-29 1992-04-23 Sankyo Co Cyclosporin-zusammensetzungen.
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5529785A (en) * 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
DE59310166D1 (de) * 1992-05-18 2001-05-31 Ciclomulsion Ag Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
EP0666752A4 (de) * 1992-10-16 1996-09-11 Smithkline Beecham Corp Therapeutische mikroemulsionen.
JPH08502490A (ja) * 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション 組成物
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ES2217368T3 (es) 2004-11-01
JP2000509021A (ja) 2000-07-18
ATE260673T1 (de) 2004-03-15
WO1997036611A1 (en) 1997-10-09
AU2588597A (en) 1997-10-22
CA2250970C (en) 2012-10-16
EP0799620A1 (de) 1997-10-08
CA2250970A1 (en) 1997-10-09
JP4212113B2 (ja) 2009-01-21
EP0799620B1 (de) 2004-03-03
DE69727849T2 (de) 2004-07-29
US5660858A (en) 1997-08-26

Similar Documents

Publication Publication Date Title
DE69727849D1 (de) Cyclosporin-Emulsionen
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
DK0759773T3 (da) Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv
AR009110A1 (es) Composicion cosmetica para mejorar la calidad de la piel humana
ATE141780T1 (de) Öl in wasser emulsionen verwendbar für die herstellung von einer creme
ATE66366T1 (de) Kortikoidhaltige zubereitung zur topischen applikation.
ES2197335T3 (es) Composiciones topicas que comprenden una emulsion de aceite en agua y un retinoide.
DE50013111D1 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
EP0402090A3 (de) Essbare Öl-in-Wasser-Emulsion
ATE380541T1 (de) Herstellung von vitaminemulsionen und konzentrate davon
ATE283031T1 (de) Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
AR002965A1 (es) Emulsión aceite-en agua transparente cuyos glóbulos de aceite tienen un tamaño promedio inferior a 100 nm y que comprede una fase lipídica anfífla, suaplicacion, procedimiento para prepararla, procedimiento de tratamiento no terapeutico que la utiliza y composicion de uso topico que la contiene.
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
DE69613647D1 (de) Wasser-in-Öl-Emulsion enthaltendes kosmetisches Präparat
BR9812934A (pt) Composição cosmética para pele
ATE307555T1 (de) Klare wasser-in-öl emulsionen
DE69130706D1 (de) Verfahren zur beseitigung von ausgelaufendem öl
DE59711769D1 (de) Öl-in-wasser-emulsionen zur wiederherstellung der lamellarität der lipidstruktur geschädigter haut
DE50013081D1 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
ES2179008T3 (es) Composicion en forma de emulsion de aceite-en-agua que contiene fibras, y sus utilizaciones principalmente cosmeticas.
ES2189891T3 (es) Emulsiones de liquidos optimizadas para la hidrolisis y uso de las mismas.
RU95102782A (ru) Косметические композиции для местного применения, вызывающие искусственный загар, способ их получения и применение
DE59812416D1 (de) Splissregenerierende haarbehandlungsmittel
FR2720228B1 (fr) Nouvelles compositions pesticides du type "émulsion huile dans l'eau".
ATE329570T1 (de) Emulsion enthaltend siliconöl- und co- lösungsmittelsystem enhaltend fettlösliche kosmetische wirkstoffe und daraus hergestelleten kosmetischen zubereitungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition